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Sa˜o Carlos, SP, BrazilABSTRACT Nuclear hormone receptors (NRs) are major targets for pharmaceutical development. Many experiments demon-
strate that their C-terminal Helix (H12) is more flexible in the ligand-binding domains (LBDs) without ligand, this increased
mobility being correlated with transcription repression and human diseases. Crystal structures have been obtained in which
the H12 is extended, suggesting the possibility of large amplitude H12 motions in solution. However, these structures were
interpreted as possible crystallographic artifacts, and thus the microscopic nature of H12 movements is not well known. To
bridge the gap between experiments and molecular models and provide a definitive picture of H12 motions in solution, extensive
molecular dynamics simulations of the peroxisome proliferator-activated receptor-g LBD, in which the H12 was bound to a
fluorescent probe, were performed. A direct comparison of the modeled anisotropy decays to time-resolved fluorescence anisot-
ropy experiments was obtained. It is shown that the decay rates are dependent on the interactions of the probe with the surface
of the protein, and display little correlation with the flexibility of the H12. Nevertheless, for the probe to interact with the surface of
the LBD, the H12 must be folded over the body of the LBD. Therefore, the molecular mobility of the H12 should preserve the
globularity of the LBD, so that ligand binding and dissociation occur by diffusion through the surface of a compact receptor.
These results advance the comprehension of both ligand-bound and ligand-free receptor structures in solution, and also guide
the interpretation of time-resolved anisotropy decays from a molecular perspective, particularly by the use of simulations.INTRODUCTIONNuclear hormone receptors (NRs) are transcription regula-
tors modulated by ligand binding. They are composed of
three domains, the largest one being the ligand binding
domain (LBD). The LBD is responsible for ligand recogni-
tion, but also for coactivator and correpressor binding and
receptor dimerization (1,2). LBDs have a mostly preserved
fold through all the NR superfamily, being composed of ~12
a-helices, which pack into a three-layer sandwich motif (3),
represented in Fig. 1 A. The ligand is completely embraced
by the protein in most structures that were obtained and
believed to be functional (4). The burial of the ligand natu-
rally suggests that protein conformational changes are
required for ligand entry and release (5,6). Crystallographic
models of the ligand-free (apo) LBDs are however, scarce,
and no structure of a ligand binding intermediate is known.
The very first NR LBD structure obtained was that of the
apo-LBD of the retinoic X receptor-a (RXRa) (7). The
structures of the retinoic acid receptor-g (RARg) bound to
retinoic acid and of the thyroid hormone receptor-a (TRa)
bound to the natural ligand T3 followed (8,9). The most
striking difference between the ligand bound (holo) and
apo-structures was the position of the C-terminal Helix 12
(H12), which in the apo-RXRa structure was extended,
exposing the ligand-binding pocket, but in ligand-bound
RARg and TRa were packed over the body of the LBD,
completely burying the ligand (Fig. 1, A and B) (7–9).Submitted June 3, 2013, and accepted for publication July 22, 2013.
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0006-3495/13/10/1670/11 $2.00This difference immediately suggested a mechanism for
ligand entry and exit from the binding pocket in which
H12 would function as a gate—this mechanism was dubbed
the mouse trap model of ligand binding, and was widely
accredited in the literature (10–15), including in textbooks
(16). The most structurally appealing interpretation of
the mouse trap model, based on the significant distension
of the C-terminal H12, is probably inaccurate: The RXRa
LBD crystal structure was a tetramer, with the H12
of one LBD unit laying over the coactivator groove of
the other unit, a possibly nonbiological interaction (7).
Furthermore, other apo-crystallographic models were
obtained in which the H12 was not extended (17,18),
resembling the ligand-bound models. Curiously, although
the increased mobility of the H12 is associated with the
ligand-free LBD, an extended-H12 ligand-bound model
was obtained for the estrogen receptor (ER) (19), with a
similar crystal packing artifact than the RXRa model.
Therefore, although the experimental evidence supporting
the existence of stable extended-H12 conformations in
solution is not strong, the existence of these conformations
in some crystal structures suggests that they might be
relevant in solution, but unlikely to crystallize due to their
increased flexibility.
Many studies have shown that the LBDs (20) and, partic-
ularly, the H12 of NRs are more flexible in the absence of
ligand (21,22), but these results do not imply that this
increased mobility is associated with the detachment of
H12 from the body of the LBD. Structural evidence is
certainly not conclusive about the extent of the H12 motionshttp://dx.doi.org/10.1016/j.bpj.2013.07.032
FIGURE 1 Structural diversity of H12 conformations found in crystallo-
graphic models. (A) Crystal structure of RAR bound to all-trans retinoic
acid (8), in which H12 traps the ligand inside the binding pocket. (B) Struc-
ture of apo-RXRa, displaying the extended H12 model, which suggested
the mouse trap model of ligand binding (7). (C) Structure of PPARg with
and without ligand (17,18), which are very similar, and (D) structure of
PPARa bound to an antagonist and a corepressor peptide (42), in which
H12 is displaced from its agonist position and partially unfolded.
Dynamics of the H12 of NR 1671in peroxisome proliferator-activated receptors (PPARs):
Structures of isoform PPARg obtained without ligand
(17,18), and with a ligand and a coactivator (18) are very
similar, as shown in Fig. 1 C, although the apo-model was
suggested to be a crystallographic artifact in which low
affinity ligands were bound and not modeled (23), or in
which crystallization was attained for the less mobile
conformer, thus forcing the C-terminal helix to pack.
NMR spectroscopy experiments have shown that the
apo-PPARg LBD is globally more mobile than the holo-
LBD, the stabilization following the binding of strong
agonists (24). The authors suggested that ligand-induced
activation shifts the conformational equilibrium from a
population of inactive conformers to the active form, instead
of a two-state switch from an inactive to an active confor-
mation. At the same time, significant displacement of the
PPARa H12 is promoted by binding of a correpressor and
an antagonist ligand, as shown in Fig. 1 D (25,26), but
H12 is not extended as in apo-RXRa.
Because the dynamics of the H12 were recognized as
being important for the regulation of the receptor activities,
it has been studied by many experimental techniques. A
notable example is the comprehensive analysis of ERmobility by fluorescence anisotropy and fluorescence reso-
nance energy transfer (27–30). Using steady-state fluores-
cence anisotropy of probes attached to the LBD of ERs,
Katzenellenbogen and co-workers (27) have shown that
ER H12 is intrinsically dynamic, and both ligand or coacti-
vator binding drive the LBD to assume a relatively rigid
structure, which is resistant to proteolysis. Coactivactors
can induce the LBD to assume stable forms, even in the
absence of ligands (28). With fluorescence resonance
energy transfer experiments, they have shown that ligand
binding also stabilizes the formation and rates of dissocia-
tion of dimers, which could be caused by H12 repositioning
over the dimerization surface (29). Furthermore, dimeriza-
tion suppressed ligand dissociation routes (29), a result to
which we later provided a structural basis (31). Addition-
ally, it was suggested that the lower subdomain of ER
LBD can adopt a loosely folded globular state, which facil-
itates ligand binding and release (30). Structural models for
denaturation intermediates were suggested for TRs by our
group and, in accordance with experiment, were shown to
be globular (32). It is natural that modeling studies follow
experimental observations, as the molecular basis for the
macroscopic experimental observations can only be inferred
from indirect evidence. Most of the time, however, it is not
possible to directly compare the experimental results with
the model data. Of course, this is due to the difficulty in
obtaining experimental data on molecular motions with
timescales accessible to current computer simulations.
The first molecular dynamics (MD) studies on NRs
addressed the problem of ligand dissociation from RARg
(33). It was shown that H12 was likely involved in ligand
dissociation, but the structures of dissociation intermediates
were not consistent with the apo-RXRa structure, because
the H12 did not extend. Our group has comprehensively
studied ligand dissociation and binding from TRs and ERs
(31,34–36). Our simulations indicate that the most favorable
dissociation paths, particularly for TRs, do not involve
major H12 displacements (34,35). For ERs, competing
dissociation mechanisms, involving or not involving H12,
were observed (31). Similar results were observed with
different simulation techniques by other groups that studied
ligand dissociation for other NRs (37–40). None of these
simulations, with RARg or any other NR LBD, imply the
large H12 structural rearrangement suggested by the apo-
RXRa structure, but it is possible to argue that the large
conformational motions required for the extension of H12
were not adequately sampled in these simulations. Never-
theless, we have also shown that only subtle conformational
perturbations of the structure of the LBD are required even
for ligand entry into the binding pocket (36). Therefore,
although the simulations may not sample every possible
conformation of the LBDs, they consistently suggest that
major structural rearrangements as the detachment of H12
from the LBD body are, at least, not required for ligand
entry or release from the binding pocket.Biophysical Journal 105(7) 1670–1680
FIGURE 2 (A) Structural model of PPARg bound to Rosiglitazone and
attached to the CysFluor fluorescent probe. (B) Detail of the CysFluor probe
and the orientation of its absorption dipole moment.
1672 Batista and Martı´nezThere is further evidence of the possible inaccuracy of
extended-H12 conformations. First, many NRs actuate as
transcription repressors in the absence of ligand (41) and
this action is mediated by corepressor proteins that bind to
the LBD. Crystallographic models of the corepressor-
LBDs complexes demonstrate that corepressor peptides
displace H12 from the agonist conformation, but that H12
remains packed over the LBD (42). Finally, recent
Hydrogen/Deuterium-exchange experiments have shown
that the H12 of TRs protects regions of the LBD in the pres-
ence or absence of ligand, thus this C-terminal helix can
bind to the surface of the LBD in both cases (22). These
macroscopic experiments provide hints on the equilibrium
of conformations probed by H12 in solution.
A definitive analysis of the extent of H12 motions in
solution requires the direct comparison of experimental
data on molecular mobility with molecular models of
receptor structure. In this work, we build a microscopic
model of H12 motions for PPARg. We obtain a molecular
representation for the only experiment providing direct
evidence on how the H12 of NRs moves with nanosecond
resolution: In 2003, Schwabe and co-workers (21) per-
formed a set of time-resolved fluorescence anisotropy
decay experiments of a probe attached to the C-terminal
residue of the PPARg LBD. The time-resolved fluorescence
anisotropy decay is directly correlated to the reorientational
motions of the probe, most specifically to the reorientation
of its transition moment vector (43,44). Once the fluores-
cent probe is excited by polarized light, it may emit by fluo-
rescence at any time following excitation, and the angle of
polarization of the emission of each fluorophore is related
to the conformational reorientation preceding emission.
Because each fluorophore reorientates differently, these
movements decrease the polarization of the overall emitted
light, and the rate of depolarization is dependent on how
fast the probes rotate in solution. In the experiment reported
by Schwabe and co-workers (21), the probe was attached to
the C-terminal residue of the LBD, in such a way that the
depolarization of the emission is determined by the move-
ments of the probe relative to the C-terminal H12, the
movements of the H12 (and, thus the probe) relative to
the LBD and, finally, to the rotation of the whole LBD in
solution (Fig. 2). Confirming previous observations, it
was observed that the decay of the anisotropy was faster
without ligand and faster also for LBD mutants causing
human diseases (21). Therefore, they confirmed experimen-
tally the general picture that H12 is more mobile in the
absence of the ligand. Nevertheless, one more time, the
analysis of the experimental data was not sufficient for
the proposition of a detailed structural model of these
motions.
Here, we explicitly simulate a complete model of the
PPARg LBD attached to the probe used by Schwabe and
co-workers (21). The time-dependence of the anisotropy
decay can be computed from the simulated motions andBiophysical Journal 105(7) 1670–1680directly compared to the experimental results, providing a
molecular level structural interpretation to their observa-
tions. We show that the observed decay rates can only be ex-
plained by the dynamics of a fluorescent probe attached to a
H12, which is predominantly folded over the body of the
LBD. The detachment of Helix 12 from the LBD implies
much faster decay rates than the ones observed experimen-
tally. Therefore, the LBD of PPARg in solution (and
possibly of most receptors) is compact, with packed-H12
conformations either in the presence or absence of ligand.
The nature of H12 movements, which are consistent with
the experimental data is shown, and its implications to the
function of PPAR and other NRs are discussed.MATERIALS AND METHODS
MD simulations were performed for PPARg bound to Rosiglitazone and to
the cysteine-fluorescein probe (CysFluor) (21), as shown in Fig. 2 A.
CHARMM27 parameters (45) were used for the protein, and previously
described CHARMM-compatible parameters (46) were used for Rosiglita-
zone. The parameters for CysFluor were obtained from group analogy
within the CHARMM27 set, if not specified. CysFluor charges were
computed using the Merz-Kollman method (47) with Gaussian03 (48) at
the Hartee-Fock level using the 6-31G(d,p) basis. Three dihedral angles
were parametrized for fitting the classical potential to the quantum-
mechanical potential energy profile, as described in the Supporting
Material, Supplementary Information 2. The parameters and simulation
protocols were validated by reproducing the time-resolved fluorescence
anisotropy decays of the CysFluor probe free in solution (21) (Supplemen-
tary Information 2). All parameters are available in the Supplementary
Information 3. All simulations were performed with NAMD (49). VMD
(50) was used for visualization and preparing figures, and the TCF module
of our in-house analysis programs (51) was used for the analysis of the time
correlation of the dipole moment of CysFluor in production runs (see
below). The TIP3P water model was used (52). It is known that the
TIP3P water model underestimates the viscosity of water (53). Therefore,
we used Langevin dynamics to introduce a friction to adjust the dynamic
properties of the water model to the experimental data. We first computed
the self-diffusion coefficient of water in simulations of pure water with
different Langevin coupling periods g (no coupling, and g ¼ 1, 5, 7, and
10 ps1). With g ¼ 10 ps1 the self-diffusion coefficient obtained from
simulation (2.32  109 m2s1) was in good agreement with the experi-
mental value (2.30  109 m2s1) (53,54). We then used this friction
coefficient in all production runs. The same water model and correction
was shown to be successful in reproducing the cis-trans transition kinetics
of peptides bonds (55).
Dynamics of the H12 of NR 1673The time-resolved anisotropy decay was modeled from the second-order







hP2½maðtÞ ,meðt þ DtÞi;
where ma and me are the absorption and emission dipole moments, P2 is the
second-order Legendre polynomial operator, and hi represents the equilib-
rium average (44). The orientation of the absorption dipole moment vector
is represented in Fig. 2 B. (44) The angles between absorption and emis-
sion dipole moments were obtained from the experimental anisotropy at
t ¼ 0, (44) and were 10.5 and 16.8 for holo- and apo-PPARg, respec-
tively. (21) The structure of PPARg bound to Rosiglitazone (Protein
Data Bank (PDB) id. 2PRG) was used. (18) The cofactor peptide was
removed, and multiple initial configurations for CysFluor bound to PPARg
were obtained by running a high-temperature (800 K) simulation in vac-
uum in which all protein and Rosiglitazone atoms were kept fixed, for
the probe to shake randomly without disturbing the protein structure. 35
aleatory configurations of the probe were extracted from this simulation
and were subject to 5000 steps of conjugate-gradient (CG) energy minimi-
zation, in vacuum, also fixing all protein atoms. The energy minimized
structures were solvated with Packmol (56,57) with water, sodium, and
chloride ions to neutralize the simulation box. The complete systems con-
tained ~74,000 atoms. The solvated structures were subject to the
following steps of minimization and equilibration: 1), 1000 CG energy
minimization and 200 ps MD keeping all protein, ligand, and probe atoms
fixed. 2), 500 CG energy minimization steps and 200 ps MD keeping all
Ca carbons fixed. 3), 2 ns MD. Production runs were 20 ns long and
were performed from the last frame of step 3 of equilibration. All simula-
tions were performed with a time step of 2 fs, with a constant temperature
(298.15 K) and pressure (1 atm) by using a Langevin temperature bath with
a damping coefficient of 10 ps1 (see above) and a Langevin piston with a
period of 200 fs, a decay rate of 100 fs, and a piston temperature of 298.15
K (the thermostat and barostat coupling timescales are much faster than the
structural motions that determine the anistropy decay rates of this study,
which are on the nanosecond timescale). A cutoff of 12 A˚ was used for
vdW interactions with switching function starting at 10 A˚. Long-range
electrostatic potential were computed using the particle mesh Ewald sum
method. Trajectory frames were recorded at every picosecond. Simulations
following similar protocols were performed for structural models of LBDs
with extended-H12 conformations. Two apo-PPARg LBD models were
built by performing steered molecular dynamics (58) (SMD) simulations
starting from the holo-PPARg LBD structure, in which H12 was pulled
apart from the LBD without ligand. Two different pulling directions
were used, from which two extended H12 conformations were obtained.
Additionally, simulations were performed with the ER structure 1A52,
(19) from which the ligand was removed, and apo-RXR (PDB id.
1LBD) (7), both experimental crystallographic models display extended-
H12 conformations. The extended-H12 simulations followed the same pro-
tocol as previous runs, but only 10 random initial orientations of the probe
were used for each model, extracted from high-temperature simulations.
The extended-H12 mandates for a much larger simulation box, and these
systems contained nearly 170,000 atoms. Finally, two auxiliary simulations
of the 2PRG PPARg model, following the same protocols, but for which
production runs lasted 500 ns, were performed; one of them differing
only because the Rosiglitazone molecule was removed. All simulations
were run in a SGI Altix XE composed of 14 nodes with Xeon X5670
CPUs and 24 Gb of RAM memory. In summary, 65 simulations of 20 ns
and 2 simulations of 500 ns were performed for solvated protein systems.
The total simulation time was, therefore, 2.3 ms, excluding equilibration
steps.
The fitting of the experimental curves by combinations of modeled re-
sults was performed by adjusting a linear combination of the computed
curves to the experimental results in the interval of 0–5 ns. The fitting
was done by implementing a constrained minimum-square fitting in whichthe contribution of each model curve was constrained to be between 0 and 1
and the sum of all contributions was unitary. Therefore, the parameters of
the fit can be interpreted as the fractions of each model curve for the compo-
sition of the experimental data. The constrained nonlinear fit model was
implemented in Fortran90 and solved with Algencan. (59) The software
implementation is freely available at http://lm-utils.googlecode.com.RESULTS AND DISCUSSION
Molecular movements and anisotropy decays in
the holo-PPAR LBD
We performed MD simulations of the fluorescent probe
CysFluor attached to the C-terminal residue of the ligand-
bound PPARg. Each simulation was initiated with a
different conformation of the CysFluor probe, to maximize
the sampling of probe conformations and possible anisot-
ropy decay rates. Simulations were performed with the
probe attached to a holo-PPARg LBD (bound to Rosiglita-
zone) with H12 in agonist conformation.
The time-dependent anisotropy decay of the fluorescent
probe is dependent on the reorientational dynamics of
its electronic transition dipole moment. Schwabe and
co-workers (21) interpreted the anisotropy decay rates by
decomposing the reorientational motion of the probe into
four components: 1), the probe internal structural fluctua-
tions (not observed); 2), the movements of the probe relative
to the helix (H12) to which it is attached; 3), the structural
fluctuations of the H12 relative to the LBD; 4), the rotations
of the LBD as a whole. The experimental time-dependent
anisotropy decay combines all these movements, which
occur in different timescales.
The multiple initial conformations that we used allowed
for the sampling of a great diversity of reorientational move-
ments of the probe. Each initial conformation of the probe
determines a different anisotropy decay rate, and a wide
variability of rates was obtained, as shown in Fig. 3. In
particular, we found configurations in which the probe
adheres to the protein and displays minimal motions and
configurations in which the probe remains detached from
the LBD during the whole simulation, displaying maximal
mobility. The simulated anisotropy decay rates for holo-
PPARg display much greater variability than those observed
for different experimental constructs. Specifically, when the
probe remains permanently attached to the LBD (upper gray
curve in Fig. 3), the decay rate is much slower than any of
the experimentally observed rates. On the contrary, when
the probe is detached from the body of the LBD (lower
curve in Fig. 3), the simulated rate is much faster than any
of the experimental results. The simulations sampled fast
decay rates preferentially, because the high-temperature
simulation used to model initial configurations generated
conformations of the probe detached from the protein
more frequently.
The experimental decays are very similar for
timescales >1 or 2 ns, because of the contribution ofBiophysical Journal 105(7) 1670–1680
FIGURE 4 Characteristic molecular mobility of the CysFluor probe
leading variable anistropy decay rates: (A) The slowest rate results from
the docking of the probe in a cleft between H11 and H12. Intermediate
decay rates result from (B) sliding of the probe onto the surface of the pro-
tein or (C) detachment from the surface in a fraction of the simulation time.
(D) Very fast decays are characteristic of a probe that does not interact with
the protein surface during the whole simulation.
FIGURE 3 Calculated anisotropy decays for each simulation (gray) of
holo-PPARg, starting from different random conformations of the probe,
in comparison with the experimentally observed (21) anisotropy decay rates
for holo-PPARg (black) and apo-PPARg (red).
1674 Batista and Martı´nezreorientational motions, which are faster than protein tum-
bling vanish. The apo- and holo-experimental decays differ
on short timescales, which are apparent before 1 ns (Fig. 3,
black and red). Depending on the initial configuration, the
reorientation of the probe in the simulations leads to a
slow, tumbling-like decay very early in the simulations, or
a full decorrelation of the anisotropy in <4 or 5 ns.
Naturally, simulations displaying early tumbling-like decay
are related to probe conformations that are tightly and
permanently adhered to the LBD. On the other side, faster
decay rates are obtained when the probe is released from
the protein surface. Conformations probed by the fluoro-
phore in representative simulations are shown in Fig. 4.
The slowest decays result from the probe being attached
with specific hydrogen bonds to the protein surface, restrain-
ing its mobility, as in Fig. 4 A. Intermediate rates are pro-
duced by conformations of the probe interacting less
tightly with the protein surface, by forming only hydropho-
bic contacts that allow for the sliding of the probe onto the
protein surface, or by the alternation of probe-attached and
probe-detached configurations (Fig. 4, B and C). The fastest
decay rates are observed when the protein does not interact
directly with the protein surface at any time during the simu-
lation, thus being able to randomly reorient (Fig. 4 D). It is
important to note that these configurations presenting a
probe detached from the LBD imply the full decorrelation
of the probe orientation in ~5 ns (lower black curve,
Fig. 4). The characteristic decay rates computed by triple-
exponential fits are 0.014, 0.32, and 41 ns for the slowest
decay, and 0.08, 0.08, and 3.31 ns for the fastest decay.
Compared to experimental fits (21) to apo-PPARg (with
characteristic times of 0.08, 4.15, and 17.8 ns) and holo-
PPARg (0.35, 14.8, and 17.8 ns), we note that the slowest
modeled decay displays one characteristic time (0.32 ns)Biophysical Journal 105(7) 1670–1680that is consistent with one characteristic time of experi-
mental holo-PPARg (0.35 ns), which might indicate that
one experimental timescale corresponds to probe move-
ments consistent with those of that simulation. Longer
simulations (see below) would be needed for a detailed
quantitative comparison of these results.
Therefore, the simulations indicate that fast decay rates
are associated with large conformational motions of the
probe, which occur when it does not interact with the protein
surface. When these configurations predominate, decay
rates are much faster than any of the experimental observa-
tions. For the tumbling-like decay to be dominant in <1 or
2 ns, the probe must be adhered to the protein surface,
restricting its conformational flexibility. Therefore, the
simulations show that the decay rates are determined by
the propensity of the CysFluor probe to be attached to the
LBD or free to rotate in solution.
Dynamics of the H12 of NR 1675Helix 12 structural fluctuations observed in Simulations
S1 and S4, displaying maximal and minimal anisotropy
decay rates, are shown in Fig. 5. During Simulation S1,
only very minor structural fluctuations are observed, result-
ing in a stable and constant root mean-square deviation
(RMSD) of ~1.5A˚. In Simulation S4, on the other side,
H12 samples two conformations, one being the crystallo-
graphic one, and a perturbed conformation, different from
the crystallographic structure in ~3.5 A˚ RMSD. This per-
turbed conformation is probably induced by the high
mobility of the CysFluor probe. Nevertheless, as shown in
Fig. 5, the highest RMSD of H12 in this simulation is still
associated with an H12, which deviates only slightly from
its agonist conformation, particularly if compared, for
example, with the displacements observed in the presence
of a corepressor peptide (25) or with the extended-H12
model of apo-RXR (Fig. 1, B and C) (7). In every simula-
tion, the reorientation of the H12, computed independently,
is slow if compared to experimental decay rates, and essen-
tially dominated by the global reorientation of the protein
(see the Supporting Material Fig. S1), supporting the depen-
dence of the anisotropy decay rates on the propensity of the
probe to be adhered, or not, to the LBD surface. Therefore,
these simulations show that there is little correlation be-
tween the anisotropy decay rates and the mobility of the pro-
tein site to which the probe is attached. Similar conclusionsFIGURE 5 Mobility of the H12 of PPARg LBD in simulations
displaying extreme decay rates (see Fig. 4). The maximum displacement
in each simulation is indicated and shown. Simulation S1 displays the
slowest decay rate and is related to minor H12 displacements. Simulation
S4 displays a decay rate much faster than experimental ones, and greater
but still subtle H12 movements.were obtained for other systems, and bring to attention
important limitations for the interpretation of experimental
fluorescence anisotropy data. (44,60)
The holo-PPARg simulations indicate that the time-
dependence of the anisotropy of the CysFluor probe attached
to H12 can span a wide range of decay rates, depending on
how the probe interacts with the surface of the LBD. The
experimentally observed rates would be better interpreted
as a combination of local motions of a probe that partially
attaches to the surface of the LBD, and partially dissociates
from it. The CysFluor probe can be rigidly attached to the
LBD if inserted within protein substructures (as in Simula-
tion S1 and Fig. 4 A), or much more mobile than expected
from the experiment, if detached from the body of the LBD
(as in Simulation S4). Because both ligand-bound and
ligand-free experimental decay rates are on the slow part of
the spectrum, the probe must be able to bind to the surface
of the protein in the most populated conformations in solu-
tion. We will show, now, that structural models representing
the H12 in extended conformation cannot provide such
a probe-protein interaction, implying that extended-H12
conformations in solution must be rare or inexistent.How frequent can extended-H12 conformations
be in PPARg?
To evaluate the possibility of extended-H12 structures being
significant for the dynamics of the LBD, we modeled the
possible anisotropy decay outcomes that could result from
a CysFluor probe attached to such LBD models. Because
there are no experimentally available structural models of
PPARg with an extended H12, two computational con-
structs of PPARg with extended-H12 were simulated,
obtained from SMD simulations in which the H12 was
induced to detach from the LBD. Additionally, we also
performed MD simulations of the two available crystallo-
graphic extended-H12 LBD structures: the ER structure
1A52 (20) and the canonical model of apo-LBD, the apo-
RXRg (1LBD) model (7) (both might be crystallographic
artifacts (7,19)). Therefore, four different structural models
were used to sample the possible interactions of the
CysFluor probe with apo-LBDs, and determine whether
experimentally observed decay rates could be interpreted
as the decay rates resulting from the reorientational
dynamics of the probe attached to these extended-H12 struc-
tures. The models are represented in Fig. 6, A–C.
The predicted time-resolved fluorescence decays for the
open-H12 models are displayed in Fig. 6. The decay is
much faster than that observed for most closed-H12 models,
resembling, on average, the fastest decay of those models.
The probe cannot form contacts to the core of the protein,
and fluctuates without major sterical impairment, resulting
in fast reorientational dynamics. In all cases, the decay rates
are significantly faster than any of the experimental
measures for apo, holo, and mutant PPARg LBDs. (21)Biophysical Journal 105(7) 1670–1680
FIGURE 6 Extended-H12 models simulated and
the computed time-resolved anisotropy responses.
The black lines represent the experimental apo-
PPARg decay (21), and gray lines are simulated
curves. All simulated curves decay much faster
than the experimental result, for all models,
because the probe cannot interact with the protein
surface. (A) PPARg models obtained from SMD
simulations (two superimposed models are
shown). (B) The apo-RXRa crystallographic
structure (7). (C) The extended-H12 ER crystallo-
graphic structure (19).
1676 Batista and Martı´nezTherefore, the experimentally observed anisotropy decays,
if having at all a contribution from extended-H12 structures,
must be compensated by the prevalence of structures in
which the probe lays down over the body of the LBD. We
will first try to reproduce the experimental curves from
single long simulations of compact LBDs, and then compute
quantitatively the frequency distribution of the different
simulated decays that best fit the experimentally obtained
rates.Modeling anisotropy decays from long
simulations of a globular PPARg
Ideally, a single simulation would be able to sample all
possible conformations of the probe and of the receptor in
such a way that the anisotropy decays computed would
reproduce the experimental results. Therefore, in view of
the fact that our previous results indicated that extended-
H12 models appeared not to be necessary for obtaining
the experimental decays, we performed relatively long sim-
ulations of the PPARg LBD starting from one of the confor-
mations used in the previous simulations. Two 500 ns
simulations were performed starting from the same model,
the Rosiglitazone ligand removed from one of the structures.
Therefore, these simulations should provide insights into the
dynamics of apo- and holo-LBDs, whenever the structure
remains compact in both cases.
The mobilities of the CysFluor probe observed in each
simulation are shown in Fig. 7. The simulations started
with conformation of the probe detached from the LBD,
in such a way that the probe displays a high conformational
variability until the instant in which it lays down over the
surface of the LBD. The instants of attachment of the probe
to the protein surface are very clear, resulting in small fluc-
tuations of the RMSD in subsets of the simulations.
Although the initial structures are identical, the mobilities
of the probe differ. In the ligand-bound simulationBiophysical Journal 105(7) 1670–1680(Fig. 7 A), the probe was observed to fluctuate until
~200 ns, when it assumed a relatively rigid conformation
by interacting with the protein surface. No major conforma-
tional changes were observed in the remaining 300 ns of
simulation.
On the other side, the probe in the ligand-free model
oscillated until ~100 ns, when it reached a less mobile state
by interacting with the protein surface. However, different
from what was observed with ligand, this conformation
was not stable. The probe deviates progressively from this
initial surface-bound state, dissociates from the surface at
~300 ns, and until the end of the simulation, transitions
between different conformations occurred ~5 times (indi-
cated by arrows). Therefore, the probe was indeed more
mobile in the ligand-free model. Each conformation of the
probe persisted for 20 to 100 ns, indicating that for
the proper sampling of this conformational variability one
would need simulations of several microseconds. The
same estimate cannot be done for the ligand-bound simula-
tions, as no interchange between conformations was
observed (therefore, the required simulations might be
much longer). Fig. 7, E and F, represent the mobility of
the CysFluor probe and of H12 in these long simulations.
A superposition of snapshots representative of the mobilities
after 200 ns is shown. The conformational variability of H12
in both simulations is similar, and the conformational vari-
ability of the probe is slightly larger in the ligand-free simu-
lation, reflecting the conformational shifts of the probe
indicated in Fig. 7 B. For each simulation, the probe persis-
tently interacted with the same region of the LBD after
laying down over the surface of the protein.
With the limited sampling provided by these simulations
in mind, we nevertheless computed the anisotropy decays
that the mobilities of the probes imply (Fig. 7, C and D).
The decay of the ligand-bound anisotropy agrees reasonably
with the experimental result in short timescales (Fig. 7 C).
The higher mobility of the probe in the ligand-free
FIGURE 7 Mobility and anisotropy decays in 500 ns-long simulations. (A) RMSD of the CysFluor probe in ligand-bound (holo) PPARg. (B) RMSD of the
CysFluor probe in ligand-free PPARg. Time-resolved anisotropy decays computed from the 500 ns simulations for (C) holo-PPARg and (D) ligand-free
PPARg. Solid lines represent the decays computed from the computational models and dashed lines the experimental observation (21). Molecular represen-
tation of the movements experienced by the CysFluor probe and the H12 in the last 300 ns of these simulations for (E) ligand free PPARg and (F)
holo-PPARg.
Dynamics of the H12 of NR 1677simulation also roughly reproduces the experimental apo-
PPARg decay (Fig. 7 F). Both simulations underestimate
the rate of the tumbling of the protein, and deviate from
the experimental result at longer timescales (this might
result from the Langevin dynamics, some protein diffusivity
limitation due to the size of the simulation box, or simply
lack of sampling, as some variability of tumbling rates
was obtained for the shorter MD simulations, as shown in
Fig. S1).Experimental decays as weighted combinations
of simulation models
We cannot precisely reproduce in a single simulation the
experimental decay rates because transitions between
dynamic states that lead to different anisotropy responses
are too rare to be sampled effectively. Therefore, we have
implemented a constrained least-square fitting approach,
(59) and obtained the best linear combination of the model
curves that reproduce the experimental observations, in each
case. The coefficients of the fit can be interpreted as the frac-
tional contribution of each model curve to the experimental
decay (or, equivalently, the percentage of the time in which
the probe displays a particular configuration in solution).This strategy is justified by the 500 ns simulations, which
show that the probe conformations persist much longer
than the timescales of interest (0 to 5 ns), and in such a
way that the experimental result can be considered a
weighted combination of the possible depolarization
outcomes.
In Fig. 8 A, we show the reconstruction of the experi-
mental holo-PPARg curve as a combination of the simulated
holo-PPARg decays. A very good fit can be obtained, as
noted by the overlap of the experimental and reconstructed
curves (black and red). The optimal combination of simu-
lated decays that fit the experimental observation is
composed by an approximate fifty-fifty combination of
models that display decays slower than the experimental
ones and models that display decays faster than the experi-
mental ones (this is not an obligatory result: if, for example,
the faster decays were slower than actually computed, their
total contribution would have to be larger than ~50% to
compensate for the slower decays).
Experimentally, the apo-PPARg decay is faster than the
holo-PPARg decay on short timescales. However, the exper-
imental apo-PPARg decay cannot be reproduced using only
extended-H12 models (Fig. 8 B), as is evident from the fact
that all these models displayed decay rates faster than theBiophysical Journal 105(7) 1670–1680
FIGURE 8 Contributions of each model for re-
producing the experimental decays. Curves with
contributions >2% are shown, and contribu-
tions >5% are labeled. The red curve is the best
least-square fitting to the experimental data, which
is depicted in black (in panels A, C, and D, the
black and red curves almost overlap). (A) Optimal
fitting of the holo-PPARg experimental decay
using all simulations of holo-PPARg LBD. (B)
Fitting of experimental apo-PPARg decay fails
using extended-H12 models, because no model
produces decay slower than the experimental
one, the best fit is simply the reproduction of the
simulated curve with the slowest decay (red).
The experimental apo-PPARg decay can be nicely
fit if considering holo-PPARg models, with (C)
a minor contribution of extended-H12 models
(blue), or (D) without extended-H12 models at all.
1678 Batista and Martı´nezexperimental ones. This indicates that one needs significant
contributions of probe conformations attached to the LBD
body to interpret the experimental observation also for
apo-PPARg. In Fig. 8 C, we computed the combination of
all simulated curves (both from holo-PPARg models and
extended-H12 PPAR models) that best reproduce the exper-
imental apo-PPARg decay. Now it is possible to reproduce
with great precision the experimental curve, which requires,
as predicted, a great contribution of probe conformations
attached to LBD—particularly the 45% contribution of the
slowest decay rate observed. The greatest contribution to
this fit coming from extended-H12 models is 5% (blue curve
in Fig. 8 C), suggesting that extended-H12 configurations
might not be required at all for the interpretation of the
experimental result. Indeed, as Fig. 8 D indicates, the fitting
of the experimental apo-PPARg decay using only the
closed-H12 holo-PPARg models is also precise. The fast
decay rates are adequately reproduced by closed-H12
models in which the probe is detached from the body of
the LBD, and the slow experimental decay at intermediate
timescales is granted by the tightly bound probes in slow-
decay models.
Therefore, the experimental decay rates can be repro-
duced if there is a significant contribution of conformations
of the probe, which are tightly attached to the LBD surface,
displaying slow-decay rates. Faster decay rates result not
from the detachment of the H12 from the body of the
LBD, but from the detachment of the probe from the LBD
body. The need of 50% contribution of configurations in
which the probe is able to lay over the LBD surface is, we
believe, a strong argument against the existence, to any
significant extent, of extended-H12 structures in solution.
In particular, if the extended-H12 configurations were
significantly populated, the experimental decays wouldBiophysical Journal 105(7) 1670–1680imply the great predominance of CysFluor-H12 interac-
tion-specific attachments in every closed-H12 conforma-
tion. We cannot rule out this possibility but it is, at least,
unlikely.
We suggest, therefore, that H12 must be folded over the
LBD in solution with or without ligand, and also if subject
to the particular mutations studied by Schwabe and co-
workers. (21) If existent at all, extended-H12 confor-
mations must be very poorly populated and most likely
do not have any role in ligand binding and dissociation,
or corepressor recruitment. Ligand or cofactor binding
must stabilize the position of H12 in agonist or antagonist
conformations in a structural equilibrium that occurs in a
receptor that remains compact, although less rigid, without
ligand. The NMR spectroscopy experiments reported by
Johnson et al. (24) are particularly consistent with this
view: as they demonstrate that the LBD of apo-PPARg is
as a whole more mobile and possibly structurally diverse,
it is natural that the probe would be less tightly attached
to its surface, although the receptor may preserve its glob-
ularity in every conformation. This model of LBD motions
is also consistent with the minor displacements required for
ligand entry and release previously discussed on the basis
of MD simulations on TRs (34,35) and other receptors
(33,37,38), and also with H/D exchange experiments on
TRs that suggest the protection of H3 by H12 in the
ligand-free receptor. (22)CONCLUSIONS
Nanosecond-resolution fluorescence anisotropy experi-
ments are one of the few experiments providing dynamic
data that can be directly compared to molecular movements
with atomic resolution obtained by simulations. With
Dynamics of the H12 of NR 1679improved computer power, software, and methods, MD
simulations have recently reached the timescales necessary
for the qualitative comparison of modeled anisotropy decay
rates with experimental data on fluorescent probes attached
to relatively large proteins. (44,60) Here, we compare the
results from MD simulations directly to experimental data
on NR LBD movements, providing limiting bounds to the
range of motions of the C-terminal H12 of PPARg.
In this work, we show that the molecular movements of a
fluorescent probe attached to the Helix 12 are consistent
with experimental anisotropy decays and correspond to
local fluctuations not involving the detachment of this helix
from the LBD. The detachment of the fluorescent probe
from the body of the LBD results in anisotropy decays,
which are much faster than any of the experimental observa-
tions reported. Therefore, the conformations of H12 in solu-
tion must permit the interaction of the probe with the surface
of the LBD, implying that the H12 cannot be extended. This
implies that ligand entry and release, and cofactor binding
or dissociation, impose structural fluctuations to H12 that
preserve the globularity of the structure. The picture of a
persistently compact LBD is consistent with many previous
experimental and simulation results.
The present results advance the comprehension of the
range of motions that H12 may undergo in solution both
in the presence or absence of ligands. We reinforce the
interpretation of extended-H12 models as crystallographic
artifacts and, thus, suggest that the mouse trap model of
ligand binding, as originally proposed, is most likely
imprecise. We do not rule out the possibility that H12 is
involved in ligand binding and dissociation to some recep-
tors, but its movements should be local if the range of
mobilities of the H12 observed here for PPARg are repre-
sentative. On the other side, we must attend to the possibil-
ity that the LBD of other receptors, particularly RXR, may
display different conformational equilibria. This study
provides the basis for the interpretation of time-resolved
fluorescence anisotropy experiments on other LBDs, as
the anisotropy decays resulting from extended-H12 models
are qualitatively different from those resulting from
compact LBDs.
More generally, our results confirm the possibility of lack
of correlation of the reorientational dynamics of the probe
and of the protein site to which it is bound. Fluorescence
anisotropy experiments must be interpreted with care,
because the experimental anisotropies might not correspond
directly to changes in the mobility of the site to which the
probe is attached. (44,60) We show that one of the mecha-
nisms for this lack of correlation might be the dissociation
of the fluorophore from the protein surface.SUPPORTING MATERIAL
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